Centerwatch

New CenterWatch study finds major differences in performance and outlook between investigative sites by size, age and setting

Tuesday, May 1, 2012 10:38 AM

Boston, Mass., May 1, 2012—Results of the 2012 CenterWatch Study of Global Investigative Sites released in today’s CenterWatch Monthly reveal wide differences in profits, growth and economic optimism between the largest and smallest sites, the youngest and oldest sites, and for-profit versus not-for-profit sites.

More... »

New CenterWatch study shows investigative sites see revenue, clinical trial volume growth amid signs of recovery

Monday, April 2, 2012 08:00 AM

Investigative sites worldwide see encouraging signs of financial recovery, according to a new 2012 CenterWatch study benchmarking global investigative site workload, staffing and financial performance.  Results of the study, published in the April issue of The CenterWatch Monthly, reveal sites are rebounding, with growth in both headcount and revenue during the past year.

More... »

Tufts CSDD receives research grant from goBalto

Thursday, November 17, 2011 02:49 PM

San Francisco-based goBalto, a developer of new generation web-based clinical research solutions, is providing a research grant for the Tufts Center for the Study of Drug Development to benchmark the clinical trial initiation process. Currently there is virtually no industry data available on the typical process that companies follow and on the amount of time that this process takes.

More... »

CenterWatch, Plutus Capital launch Clinical Trials Quarterly

Monday, October 24, 2011 10:37 AM

CenterWatch and Plutus Capital Partners have launched Clinical Trials Quarterly, a co-branded newsletter for the contract research organization (CRO) industry that expands CenterWatch’s reach to financial clients in Asia and Europe.

More... »

ACRO endorses Foreign Earnings Reinvestment Act

Wednesday, October 12, 2011 10:10 AM

The Association of Clinical Research Organizations (ACRO) supports the Foreign Earnings Reinvestment Act, bipartisan legislation introduced in the U.S. Senate last week by senators Kay Hagan (D-NC) and John McCain (R-AZ).

More... »

Study: 60% of protocols amended during clinical trials

Wednesday, September 14, 2011 10:41 AM

Nearly 60% of all protocols used in clinical trials for new drugs are amended during the study, but one-third of those changes could have been avoided, according to a new study, reported by PharmaTimes.

More... »

New data show number of principal investigators dropping 11% globally, and 20% in U.S.

Monday, April 25, 2011 08:02 AM

The number of principal investigators (P.I.s) filing 1572s worldwide has declined sharply, according to new data from the Tufts Center for the Study of Drug Development (CSDD).

More... »

Imperial acquisition of D. Anderson could signal consolidation trend in patient recruitment space

Monday, April 11, 2011 02:37 AM

Consolidation in the clinical trials industry is coming, many industry insiders say. It already has begun among drug sponsors and sporadically throughout the rest of the industry. But last week’s acquisition of D. Anderson & Co. by Imperial could mark the beginning of consolidation in the patient recruiting space.

More... »

Medpace Acquires European CRO, Has Big Plans for Growth

Thursday, January 21, 2010 06:04 PM

Cincinnati-based contract research organization (CRO) Medpace acquired European CRO Medical Consulting Dr. Schlichtiger for an undisclosed sum.

More... »

CenterWatch Announces May Release of “State of the Clinical Trials Industry”

Friday, April 17, 2009 08:00 AM

CenterWatch, a global source for clinical trials information, announced today the planned release of its fifth edition of the annual sourcebook, State of the Clinical Trials Industry, due out in late May.

More... »